1 recruiting, 1 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Recruiting 1, Unknown 1 |
Follow ANCA Associated Vasculitis: new trials by email Literature Review of ANCA Associated Vasculitis trials Research Report on ANCA Associated Vasculitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial to Evaluate the Efficacy of Pioglitazone to Promote Renal Tolerance in ANCA-associated Vasculitis - RENATO Trial Pioglitazone (ACTOS®), Placebo of Pioglitazone - ANCA Associated Vasculitis, Rapidly Progressive Glomerulonephritis | Phase 3 | Recruiting | Assistance Publique - Hôpitaux de Paris | 126 | 2023-10-24 | 2026-07-01 |
| Exploring Durable Remission With Rituximab in Antineutrophil Cytoplasmic Antibody(ANCA)-Associated Vasculitis Rituximab, endoxan, Methylprednisolone - ANCA Associated Vasculitis | Phase 3 | Unknown | Leiden University Medical Center | 100 | 2019-05-03 | 2023-12-14 |
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (2) · Renal Insufficiency (1) · Vasculitis (1)
Autoimmune Diseases (2) · Cardiovascular Diseases (2) · Immune System Diseases (2) · Skin Diseases (2) · Skin Diseases, Vascular (2) · Skin and Connective Tissue Diseases (2) · Systemic Vasculitis (2) · Vascular Diseases (2) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Urogenital Diseases (1) · Urologic Diseases (1) · Vasculitis (1)
Adrenal Cortex Hormones (1) · Cyclophosphamide (1) · Methylprednisolone (1) · Methylprednisolone Hemisuccinate (1) · Pioglitazone (1) · Prednisolone (1) · Rituximab (1)
Assistance Publique - Hôpitaux de Paris (1) · Leiden University Medical Center (1)
France (1) · Netherlands (1)
Alexandre Karras (1)